Literature DB >> 3835174

Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.

I Romics, J Horváth, J Fehér, A Csontai.   

Abstract

Ten patients who had undergone repeated surgical interventions for bladder papilloma with successive recurrences within intervals of a few months, were given levamisol in weekly doses of 300 mg over a year, and were followed up for various cellular immune reactions, as well as for serum globulin and for acute-phase protein concentrations in the course of treatment. Levamisol was found to act primarily on cell-borne responsiveness. The recurrence-free intervals increased in the course of treatment. Four patients have remained free from recurrences since the start of treatment.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3835174     DOI： 10.1007/bf02083502

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  10 in total

1.  Phytohemagglutinin skin test in cancer patients: correlation with in vitro lymphocyte blastogenesis to mitogens and total E-rosette forming lymphocyte count.

Authors:  S Sone; T Sano; H Ohguchi; K Yata; E Tsubura
Journal:  Tokushima J Exp Med       Date:  1977-12

2.  Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.

Authors:  G Renoux; M Renoux
Journal:  Nat New Biol       Date:  1972-12-13

3.  Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer.

Authors:  D Tripodi; L C Parks; J Brugmans
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  [Immune reactivity of patients with bladder tumors].

Authors:  I Romics; J Fehér; J Horváth; L Kisbenedek; F Balogh
Journal:  Orv Hetil       Date:  1981-07-26       Impact factor: 0.540

6.  [Immunostimulating effect of an imidotiiazole in the immunization of mice against Brucella abortus infection].

Authors:  G Renoux; M Renoux
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1971-01-11

7.  Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report.

Authors:  R B Smith; J Dekernion; B Baron; D G Skinner; J J Kaufman
Journal:  J Urol       Date:  1978-03       Impact factor: 7.450

8.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

9.  Simple method of circulating immune complex detection in human sera by polyethylene glycol precipitation.

Authors:  V Hasková; J Kaslík; I Ríha; I Matl; J Rovenský
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-06

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307
  10 in total
  2 in total

1.  Immune studies by the use of Multitest-Merieux in patients with kidney tumours.

Authors:  I Romics; D Répássy; G Kulcsár; P Brühl
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

2.  Study of cytotoxicity against adenovirally transformed cells in patients with tumours of the urinary tract.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.